---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-069747"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2023-12-12T23:59:59+00:00"
generated_at: "2026-06-07T14:15:32.947000+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Crinetics amends bylaws to adopt universal proxy rules and enhance stockholder proposal disclosures

## Summary
- Amended bylaws to comply with SEC universal proxy rules, requiring compliance with Rule 14a-19 for soliciting proxies.
- Enhanced procedural and disclosure requirements for stockholder nominations and proposals, including additional background info.
- Requires stockholder solicitors to use a proxy card color other than white.
- Amendments effective December 6, 2023; include technical and clarifying changes.

## SEC filing metadata
- accession: 0000950170-23-069747
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2023-12-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000095017023069747/0000950170-23-069747-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000095017023069747/crnx-20231206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-069747
- JSON: https://secwatch.observer/filing/0000950170-23-069747.json
- Plain text: https://secwatch.observer/filing/0000950170-23-069747.txt

## Key facts
- Governance Changes
  Crinetics Pharmaceuticals, Inc.: Amended bylaws to address universal proxy rules, enhance stockholder nomination and proposal disclosure requirements, and require a non-white proxy card color for stockholders soliciting proxies (effective 2023-12-06).
  - Change: bylaw amendment
  - Effective: 2023-12-06
  source text: On December 6, 2023, the Board of Directors (the “Board”) of Crinetics Pharmaceuticals, Inc. (the “Company”) adopted amendments to the Company’s amended and restated bylaws (as amended, the “Amended and Restated Bylaws”), which became effective the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1658247/000095017023069747/0000950170-23-069747-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.